Cosmo pharmaceuticals

At Cosmo, we are committed to improve peoples lives by developing products that address unmet medical needs in the fields of gastroenterology, dermatology and healthtech.

Investors

Latest News

18 Oct 2024

Cosmo shareholders approved Board proposal to appoint new independent auditor at today’s EGM

Read More
11 Oct 2024
AD HOC

Cosmo Pharmaceuticals appoints new Chief Financial Officer

Read More
23 Sep 2024

Cosmo Pharmaceuticals enhances Management Team with newly appointed Head of Global Business Development

Read More

Upcoming Events

11 Nov 2024-14 Nov 2024

UBS Global Healthcare Conference – Rancho Palos Verdes, California

Add to Outlook
19 Nov 2024-21 Nov 2024

Jefferies London Healthcare Conference

Add to Outlook

Latest presentation

24 Jul 2024
Half-Year Results 2024 Webcast Presentation

Therapeutic Focus

Cosmo’s therapeutic focus is on the treatment of gastrointestinal diseases (including IBD, colonic infections and colorectal cancer – CRC), increase the effectiveness of endoscopic examinations and to treat persistent skin conditions, like acne, and androgenetic alopecia, that have a long-term physical and emotional impact on lives and self-esteem.

Find out more

Our Mission

To improve people’s lives by developing products that address unmet medical needs in the fields of gastroenterology, dermatology and healthtech.

Find out more

Manufacturing

We provide services related to the production of pharmaceutical products as: assessment of manufacturing processes, technology transfer, evaluation of pharmaceutical product stability, testing and release to the market and drafting of the necessary documentation for pharmaceutical products’ registration.

Find out more